Chiesi Group

Chiesi Group International pharmaceutical Group certified B Corp.

15/04/2026

Some challenges are visible, others quietly shape everyday life. For people living with , symptoms often influence the rhythm of each day.

During Fabry Disease Month, we’re reminded how meaningful small moments can be. Whether it’s spending time with family, enjoying a hobby, or simply finding a few minutes of stillness, these moments can offer a sense of grounding — the strength needed to face what the disease brings.

Chiesi Global Rare Diseases

Behind the data, there are people who listen, connect, and build trust. On International Medical Science Laison Day, we ...
27/03/2026

Behind the data, there are people who listen, connect, and build trust.

On International Medical Science Laison Day, we celebrate the MSLs who turn science into meaningful conversations, bringing insights from the field, supporting clinicians, and helping keep patients at the heart of every decision.
Discover the voices of our MSL colleagues and how their work contributes to the shared purpose of improving the patient journey.

18/03/2026

Every patient's story is unique. Each one offers a perspective that helps us look beyond clinical needs and better understand the human experience of care.
Listening to patients allows us to notice what might otherwise be missed - where things feel unclear, where support falls short, and what truly makes a difference along the way. These insights guide how we improve, step by step.

Take a moment to listen to the community's voices as they share their experiences throughout their journeys - because understanding begins with listening.

Equity means more than metrics: it’s a journey to foster access, visibility, and meaningful support for every talent.At ...
08/03/2026

Equity means more than metrics: it’s a journey to foster access, visibility, and meaningful support for every talent.
At Chiesi, we keep empowering women at every stage of their career by providing equal opportunities and fair pay, ensuring balanced gender representation in leadership roles, and supporting their growth through dedicated mentoring, coaching, and networking programs.

This , we celebrate progress and reaffirm our commitment to creating an environment where women can thrive.

28/02/2026

Listening connects us, to each other, to our communities, and to people living with rare diseases around the world.

This , through our immersive “Sound of Rare” experience, colleagues across the globe took a moment to truly listen to the voices and stories of the rare disease community.

Afterward, each person wrote down one key learning. Every note was then linked together to form a paper chain, a visual reminder of how listening brings us closer and strengthens our connection as a global community.
Learn more at: https://www.rarediseaseday.org/

Chiesi Global Rare Diseases

Tackling climate-related respiratory disease means tackling inequality.The most vulnerable communities breathe dirtier a...
12/02/2026

Tackling climate-related respiratory disease means tackling inequality.

The most vulnerable communities breathe dirtier air, face longer allergy seasons, and often miss early diagnosis. Non-physiological factors—income, housing, occupation, education, access to care and local air quality—have the greatest influence on lung health.

While pollution remains Europe’s biggest environmental health challenge, we have the power to change that.
By acting now, Europe can lead the way with cleaner cities, stronger health systems, and safer workplaces—helping to prevent asthma and COPD (Chronic Obstructive Pulmonary Disease) and protect those most at risk. Together, we can turn this challenge into progress.

Learn more at: https://ow.ly/OBYf50Yebt7

11/02/2026

From discovery to regulatory affairs, our colleagues advance science every day to improve people’s lives.

On the International Day of Women and Girls in Science, we celebrate the passion, ideas and vision of the women in our R&D community and share what inspires them to keep moving science forward.

Meet the people behind the progress!👩‍🔬

È stata rinnovata la certificazione UNI/PdR 125 sulla parità di genere per Chiesi Farmaceutici S.p.A. e Chiesi Italia, u...
22/01/2026

È stata rinnovata la certificazione UNI/PdR 125 sulla parità di genere per Chiesi Farmaceutici S.p.A. e Chiesi Italia, un riconoscimento che premia il nostro impegno costante nel garantire equità e inclusione in ogni ambito della vita aziendale.

La parità di genere è parte integrante della nostra cultura: garantiamo equità retributiva, trasparenza e politiche di welfare che supportano ogni fase della vita, inclusi i congedi di genitorialità retribuiti al 100% per tutti i genitori.

Questo risultato rappresenta un ulteriore passo avanti verso un ambiente di lavoro in cui ciascuno può esprimere pienamente il proprio potenziale.

20/01/2026

Understanding patients' needs is the starting point for real innovation in healthcare.

At Chiesi, the Patient Journey framework is central to our patient-driven approach. It helps us map every step, from the awareness of health conditions and risk factors to diagnosis, treatment, and follow-up care.

By capturing not only the patient’s experience but also the perspectives of all stakeholders involved, it enables us to co-create integrated, sustainable solutions that go beyond the product.

🎥 Watch Noemi's video to learn how we turn insights into impact.

We’re proud to share that Chiesi has been recertified as a  !  This global recognition highlights our ongoing dedication...
15/01/2026

We’re proud to share that Chiesi has been recertified as a !
This global recognition highlights our ongoing dedication to fostering a workplace where everyone can grow, succeed, and create a meaningful impact.

In 2026, we achieved the certification in Italy, Germany, France, Spain, UK, Greece, Poland, United States and China!
Together we are shaping a workplace committed to excellence and innovation, where everyone can access opportunities and contribute to have an impact.

👏 A huge congratulations to our colleagues at Chiesi Italia, Chiesi France, Chiesi Deutschland, Chiesi Hellas, Chiesi España & Portugal, Chiesi UK, Chiesi Polska, Chiesi USA, Chiesi China and all those who made this achievement possible!

08/01/2026

Not every journey into the world goes exactly as planned.

For over 30 years, we’ve been dedicated to improving neonatal care: setting new standards, developing innovative solutions, and being there for families when it matters most.

When a baby is born before 37 weeks, it’s considered premature — a circumstance that touches 1 in 10 newborns and countless families worldwide.
Learn more about prematurity 👉

23/12/2025

90 years of countless stories and one shared purpose.

From a small lab in Parma to a global company, our journey has been driven by generations of passionate people.
Almost 2,000 colleagues came together in Parma to celebrate a legacy of progress, purpose, and innovation.

Wishing you Happy Holidays and a wonderful start to the new year. Here’s to shaping the next chapter together!

Indirizzo

Via Palermo 26A
Parma
43122

Notifiche

Lasciando la tua email puoi essere il primo a sapere quando Chiesi Group pubblica notizie e promozioni. Il tuo indirizzo email non verrà utilizzato per nessun altro scopo e potrai annullare l'iscrizione in qualsiasi momento.

Contatta Lo Studio

Invia un messaggio a Chiesi Group:

Condividi

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Who we are

Chiesi is an international company originated in Parma, with 85 years of experience and a strong focus on research, development, production and commercialization of innovative therapeutic solutions in the Respiratory, Neonatology, Rare Diseases and Special Care Therapeutic Areas. We are value-oriented, passionate, supportive and a global family with nearly 6.000 employees and 29 affiliates who have a real impact on people's lives in 90 countries around the world. With a turnover of nearly €2 billion sales, we are among the top 50 pharmaceutical companies in the world. Chiesi is the largest global pharmaceutical Group to be awarded B Corp Certification, a recognition of high social and environmental standards. We want to use business as a force for good and create a positive impact on people, environment and community.